Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Role of JNK, MEK and adenylyl cyclase signalling in speed and directionality of enteric neural crest-derived cells.

Hao MM, Bergner AJ, Nguyen HTH, Dissanayake P, Burnett LE, Hopkins CD, Zeng K, Young HM, Stamp LA.

Dev Biol. 2019 Jul 12. pii: S0012-1606(19)30197-6. doi: 10.1016/j.ydbio.2019.07.007. [Epub ahead of print]

PMID:
31306639
2.

A population of nonneuronal GFRα3-expressing cells in the bone marrow resembles nonmyelinating Schwann cells.

Thai J, Green AC, Stamp LA, Spencer NJ, Purton LE, Ivanusic J.

Cell Tissue Res. 2019 Jul 14. doi: 10.1007/s00441-019-03068-w. [Epub ahead of print]

PMID:
31302761
3.

Associations of gout and baseline serum urate with cardiovascular outcomes: analysis of the Coronary Disease Cohort Study.

Stamp LK, Frampton C, Drake J, Doughty RN, Troughton RW, Richards AM.

Arthritis Rheumatol. 2019 Jun 4. doi: 10.1002/art.41007. [Epub ahead of print]

PMID:
31162825
4.

Tapering biologic therapy for people with rheumatoid arthritis in remission: A review of patient perspectives and associated clinical evidence.

Stamp LK, Chan SJ, Marra C, Helme C, Treharne GJ.

Musculoskeletal Care. 2019 May 30. doi: 10.1002/msc.1404. [Epub ahead of print] Review.

PMID:
31148375
5.

Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual energy CT imaging study of a randomized controlled trial.

Dalbeth N, Billington K, Doyle A, Frampton C, Tan P, Aati O, Allan J, Drake J, Horne A, Stamp LK.

Arthritis Rheumatol. 2019 May 13. doi: 10.1002/art.40929. [Epub ahead of print]

PMID:
31081595
6.

Winds of change in imaging of calcium crystal deposition diseases.

Becce F, Viry A, Stamp LK, Pascart T, Budzik JF; MARS Collaboration, Raja A.

Joint Bone Spine. 2019 May 5. pii: S1297-319X(19)30068-5. doi: 10.1016/j.jbspin.2019.04.005. [Epub ahead of print] No abstract available.

PMID:
31067507
7.

Improving gout education from patients' perspectives: a focus group study of Māori and Pākehā people with gout.

Rolston CJ, Conner TS, Stamp LK, Neha T, Pitama S, Fanning N, Janes R, Judd A, Hudson B, Hegarty RM, Treharne GJ.

J Prim Health Care. 2018 Oct;10(3):194-200. doi: 10.1071/HC18010.

PMID:
31039932
8.

Clinical Utility of Multi-Energy Spectral Photon-Counting Computed Tomography in Crystal Arthritis.

Stamp LK, Anderson NG, Becce F, Rajeswari M, Polson M, Guyen O, Viry A, Choi C, Kirkbride TE, Raja AY.

Arthritis Rheumatol. 2019 Jul;71(7):1158-1162. doi: 10.1002/art.40848. Epub 2019 May 28.

PMID:
30714678
9.

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank.

Narang RK, Topless R, Cadzow M, Gamble G, Stamp LK, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2019 Jan 9;21(1):13. doi: 10.1186/s13075-018-1787-5.

10.

No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat.

Stamp LK, Topless R, Miner JN, Dalbeth N, Merriman T.

Rheumatology (Oxford). 2019 Mar 1;58(3):547-548. doi: 10.1093/rheumatology/key423. No abstract available.

PMID:
30597115
11.

Prevention and treatment of gout.

Stamp LK, Dalbeth N.

Nat Rev Rheumatol. 2019 Feb;15(2):68-70. doi: 10.1038/s41584-018-0149-7. No abstract available.

PMID:
30546062
12.

The enteric neural crest progressively loses capacity to form enteric nervous system.

Zhang D, Rollo BN, Nagy N, Stamp L, Newgreen DF.

Dev Biol. 2019 Feb 1;446(1):34-42. doi: 10.1016/j.ydbio.2018.11.017. Epub 2018 Dec 7.

PMID:
30529057
13.

Fine scale differences within the vagal neural crest for enteric nervous system formation.

Simkin JE, Zhang D, Stamp LA, Newgreen DF.

Dev Biol. 2019 Feb 1;446(1):22-33. doi: 10.1016/j.ydbio.2018.11.007. Epub 2018 Nov 16.

PMID:
30448439
14.

How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose.

Stamp LK, Chapman PT, Barclay ML, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Arthritis Res Ther. 2018 Nov 16;20(1):255. doi: 10.1186/s13075-018-1755-0.

15.

Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional study.

Yeo E, Palmer SC, Chapman PT, Frampton C, Stamp LK.

Intern Med J. 2019 Jul;49(7):838-842. doi: 10.1111/imj.14163.

PMID:
30426652
16.

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

Stamp LK, Wright DFB, Dalbeth N.

Br J Clin Pharmacol. 2019 Jun;85(6):1378-1379. doi: 10.1111/bcp.13798. Epub 2018 Nov 12. No abstract available.

PMID:
30421456
17.

Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation.

Turner R, Brennan SO, Ashby LV, Dickerhof N, Hamzah MR, Pearson JF, Stamp LK, Kettle AJ.

J Biol Chem. 2018 Dec 21;293(51):19886-19898. doi: 10.1074/jbc.RA118.005237. Epub 2018 Nov 1.

PMID:
30385504
18.

Reply.

Choi H, Neogi T, Stamp L, Dalbeth N, Terkeltaub R.

Arthritis Rheumatol. 2019 Mar;71(3):481-482. doi: 10.1002/art.40742. Epub 2019 Feb 7. No abstract available.

PMID:
30295436
19.

ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.

Stamp LK, Wallace M, Roberts RL, Frampton C, Miner JN, Merriman TR, Dalbeth N.

Drug Metab Pharmacokinet. 2018 Dec;33(6):241-242. doi: 10.1016/j.dmpk.2018.09.002. Epub 2018 Sep 18. No abstract available.

PMID:
30274827
20.

Expert opinion on emerging urate-lowering therapies.

Stamp LK, Merriman TR, Singh JA.

Expert Opin Emerg Drugs. 2018 Sep;23(3):201-209. doi: 10.1080/14728214.2018.1527899. Review.

PMID:
30244605
21.

Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation.

McKelvey KJ, Millier MJ, Doyle TC, Stamp LK, Highton J, Hessian PA.

PLoS One. 2018 Aug 16;13(8):e0202135. doi: 10.1371/journal.pone.0202135. eCollection 2018.

22.

The relationship between ferritin and urate levels and risk of gout.

Fatima T, McKinney C, Major TJ, Stamp LK, Dalbeth N, Iverson C, Merriman TR, Miner JN.

Arthritis Res Ther. 2018 Aug 15;20(1):179. doi: 10.1186/s13075-018-1668-y.

23.

Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Rheumatology (Oxford). 2018 Dec 1;57(12):2183-2189. doi: 10.1093/rheumatology/key237.

PMID:
30107437
24.

Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.

Barclay ML, Karim S, Helms ETJ, Keating PE, Hock B, Stamp LK, Schultz M.

Intern Med J. 2019 Apr;49(4):513-518. doi: 10.1111/imj.14064.

PMID:
30091273
25.

A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving Methotrexate.

Stamp LK, OʼDonnell JL, Frampton C, Drake J, Zhang M, Barclay M, Chapman PT.

J Clin Rheumatol. 2018 Jul 11. doi: 10.1097/RHU.0000000000000848. [Epub ahead of print]

PMID:
30001258
26.

Mediation analysis to understand genetic relationships between habitual coffee intake and gout.

Hutton J, Fatima T, Major TJ, Topless R, Stamp LK, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2018 Jul 5;20(1):135. doi: 10.1186/s13075-018-1629-5.

27.

Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin.

Roberts RL, Wallace MC, Harrison AA, White D, Dalbeth N, Stamp LK, Ching D, Highton J, Merriman TR, Robinson PC, Brown MA, Stebbings SM.

PeerJ. 2018 Jun 26;6:e5088. doi: 10.7717/peerj.5088. eCollection 2018.

28.

Publisher Correction: Kif1bp loss in mice leads to defects in the peripheral and central nervous system and perinatal death.

Hirst CS, Stamp LA, Bergner AJ, Hao MM, Tran MX, Morgan JM, Dutschmann M, Allen AM, Paxinos G, Furlong TM, McKeown SJ, Young HM.

Sci Rep. 2018 Jun 8;8(1):9085. doi: 10.1038/s41598-018-26661-5.

30.

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.

Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, da Rocha Castelar-Pinheiro G, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2019 Mar;71(3):427-434. doi: 10.1002/acr.23607.

PMID:
29799677
31.

Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island Samples.

Ton KNT, Cree SL, Gronert-Sum SJ, Merriman TR, Stamp LK, Kennedy MA.

Front Genet. 2018 Apr 30;9:152. doi: 10.3389/fgene.2018.00152. eCollection 2018.

32.

Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.

Krishnan M, Major TJ, Topless RK, Dewes O, Yu L, Thompson JMD, McCowan L, de Zoysa J, Stamp LK, Dalbeth N, Harré Hindmarsh J, Rapana N, Deka R, Eng WWH, Weeks DE, Minster RL, McGarvey ST, Viali S, Naseri T, Sefuiva Reupena M, Wilcox P, Grattan D, Shepherd PR, Shelling AN, Murphy R, Merriman TR.

Diabetologia. 2018 Jul;61(7):1603-1613. doi: 10.1007/s00125-018-4623-1. Epub 2018 May 2.

33.

Greenshell™ Mussels: A Review of Veterinary Trials and Future Research Directions.

Eason CT, Adams SL, Puddick J, Romanazzi D, Miller MR, King N, Johns S, Forbes-Blom E, Hessian PA, Stamp LK, Packer MA.

Vet Sci. 2018 Mar 27;5(2). pii: E36. doi: 10.3390/vetsci5020036. Review.

34.

Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.

Stamp L, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

Semin Arthritis Rheum. 2018 Oct;48(2):293-301. doi: 10.1016/j.semarthrit.2018.02.009. Epub 2018 Feb 21.

PMID:
29566967
35.

Re: "Widespread prevalence of a CREBRF variant among Māori and Pacific children is associated with weight and height in early childhood".

Major TJ, Krishnan M, Topless RK, Dewes O, Thompson J, Zoysa J, Stamp LK, Dalbeth N, Deka R, Weeks DE, Minster RL, Wilcox P, Grattan D, Shepherd PR, Shelling AN, Murphy R, Merriman TR.

Int J Obes (Lond). 2018 Jul;42(7):1389-1391. doi: 10.1038/s41366-018-0025-1. Epub 2018 Mar 6. No abstract available.

36.

An association of smoking with serum urate and gout: A health paradox.

Fanning N, Merriman TR, Dalbeth N, Stamp LK.

Semin Arthritis Rheum. 2018 Jun;47(6):825-842. doi: 10.1016/j.semarthrit.2017.11.004. Epub 2017 Nov 22. Review.

PMID:
29398126
37.

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.

Wallace MC, Roberts RL, Nanavati P, Miner JN, Dalbeth N, Topless R, Merriman TR, Stamp LK.

Rheumatology (Oxford). 2018 Apr 1;57(4):656-660. doi: 10.1093/rheumatology/kex467. Review.

PMID:
29342288
38.

Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease.

Barclay ML, Stamp LK.

Aliment Pharmacol Ther. 2018 Feb;47(4):535-536. doi: 10.1111/apt.14465. No abstract available.

PMID:
29341275
39.

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.

Wright DFB, Dalbeth N, Phipps-Green AJ, Merriman TR, Barclay ML, Drake J, Tan P, Horne A, Stamp LK.

Br J Clin Pharmacol. 2018 May;84(5):937-943. doi: 10.1111/bcp.13516. Epub 2018 Feb 20.

40.

How to prevent allopurinol hypersensitivity reactions?

Stamp LK, Barclay ML.

Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i35-i41. doi: 10.1093/rheumatology/kex422. Review.

PMID:
29272508
41.

The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Arthritis Res Ther. 2017 Dec 21;19(1):283. doi: 10.1186/s13075-017-1491-x.

42.

Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.

Stamp LK, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

J Rheumatol. 2018 Mar;45(3):419-424. doi: 10.3899/jrheum.170911. Epub 2017 Dec 15.

PMID:
29247147
43.

Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand.

Gosling AL, Boocock J, Dalbeth N, Harré Hindmarsh J, Stamp LK, Stahl EA, Choi HK, Matisoo-Smith EA, Merriman TR.

Ann Rheum Dis. 2018 Apr;77(4):571-578. doi: 10.1136/annrheumdis-2017-212416. Epub 2017 Dec 15.

PMID:
29247128
44.

Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators.

Gath ME, Stamp LK, Aimer P, Stebbings S, Treharne GJ.

Musculoskeletal Care. 2018 Mar;16(1):139-146. doi: 10.1002/msc.1227. Epub 2017 Dec 13.

PMID:
29235264
45.

Digital-PCR for gene expression: impact from inherent tissue RNA degradation.

Millier MJ, Stamp LK, Hessian PA.

Sci Rep. 2017 Dec 8;7(1):17235. doi: 10.1038/s41598-017-17619-0.

46.

Kif1bp loss in mice leads to defects in the peripheral and central nervous system and perinatal death.

Hirst CS, Stamp LA, Bergner AJ, Hao MM, Tran MX, Morgan JM, Dutschmann M, Allen AM, Paxinos G, Furlong TM, McKeown SJ, Young HM.

Sci Rep. 2017 Nov 30;7(1):16676. doi: 10.1038/s41598-017-16965-3. Erratum in: Sci Rep. 2018 Jun 8;8(1):9085.

47.

Brief Report: Validation of a Definition of Flare in Patients With Established Gout.

Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Bourke S, Louthrenoo W, Vazquez-Mellado J, Hernández-Llinas H, Neogi T, Vargas-Santos AB, da Rocha Castelar-Pinheiro G, Amorim RBC, Uhlig T, Hammer HB, Eliseev M, Perez-Ruiz F, Cavagna L, McCarthy GM, Stamp LK, Gerritsen M, Fana V, Sivera F, Taylor W.

Arthritis Rheumatol. 2018 Mar;70(3):462-467. doi: 10.1002/art.40381. Epub 2018 Feb 6.

48.

Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis.

McQueen FM, Chapman P, Pollock T, D'Souza D, Lee AC, Dalbeth N, Stamp L, Lindsay K, Doyle A.

Arthritis Res Ther. 2017 Oct 24;19(1):241. doi: 10.1186/s13075-017-1433-7.

49.

Rates of Joint Replacement Surgery in New Zealand, 1999-2015: A Comparison of Rheumatoid Arthritis and Osteoarthritis.

Stamp LK, Haslett J, Chapman P, O'Donnell J, Raja R, Rothwell A, Frampton C, Hooper G.

J Rheumatol. 2017 Dec;44(12):1823-1827. doi: 10.3899/jrheum.170551. Epub 2017 Oct 15.

PMID:
29032353
50.

Lack of Evidence that Soluble Urate Directly Influences Bone Remodelling: A Laboratory and Clinical Study.

Dalbeth N, Pool B, Chhana A, Lin JM, Tay ML, Tan P, Callon KE, Naot D, Horne A, Drake J, Gamble GD, Reid IR, Grey A, Stamp LK, Cornish J.

Calcif Tissue Int. 2018 Jan;102(1):73-84. doi: 10.1007/s00223-017-0328-6. Epub 2017 Oct 10.

PMID:
29018897

Supplemental Content

Support Center